Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

MRM Health has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) ...

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory ...

A campaign launched by Jacksonville Jaguars edge rusher Josh Hines-Allen has raised $40,000 for childhood cancer charities.

That’s when the tears began to flow. At first, I was embarrassed. The vulnerability of the moment left me exposed like never ...

Background Inflammatory bowel disease (IBD) arises from complex interactions among diet, host and gut microbiome. Although diet influences intestinal inflammation, the microbial and metabolic pathways ...

CAR-T cell therapy provides long, treatment-free remissions for relapsed multiple myeloma, using genetically modified T cells ...

Fortis Hospital Bannerghatta Road in Bengaluru delivered exceptional multidisciplinary care in a rare and life-threatening ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

Risk factors for relapse after reinduction treatment with rituximab in patients with antineutrophil cytoplasmic ...

Detailed price information for Aptevo Therapeutics Inc (APVO-Q) from The Globe and Mail including charting and trades.